small molecule

TIMENTIN IN PLASTIC CONTAINER

CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM

Loss of exclusivityloss of exclusivity
CompanyGLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND

Drug detail

Brand nameTIMENTIN IN PLASTIC CONTAINER
Active ingredientCLAVULANATE POTASSIUM; TICARCILLIN DISODIUM
StrengthEQ 100MG BASE/100ML;EQ 3GM BASE/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 1989
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TIMENTIN IN PLASTIC CONTAINER patent cliff — loss of exclusivity — | CliffBio